Medical Costs Associated with Insomnia Treatment with Suvorexant Monotherapy in Japan: Results from a Retrospective Cohort Study Using a Large-Scale Claims Database

BACKGROUND: The association of insomnia treatment with medical costs is not well characterized in Japan, despite the high economic burden of insomnia. OBJECTIVE: The aim of this study was to investigate the impact of suvorexant, the first dual orexin receptor antagonist, on direct medical costs in i...

Descripción completa

Detalles Bibliográficos
Autores principales: Uchiyama, Makoto, Ito, Kaoru, Okumura, Yasuyuki, Yi, Jingbo, Crawford, Bruce, Abe, Machiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114234/
https://www.ncbi.nlm.nih.gov/pubmed/35129832
http://dx.doi.org/10.1007/s40801-021-00279-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114234/
https://www.ncbi.nlm.nih.gov/pubmed/35129832
http://dx.doi.org/10.1007/s40801-021-00279-y

Ejemplares similares